<?xml version="1.0" encoding="UTF-8"?>
<p id="para380">A timeline of the typical clinical course of severe SARS-CoV-2 infection is shown in 
 <xref rid="fig1" ref-type="fig">figure 1</xref> , based on authors' local data and published case series.
 <xref rid="bib13" ref-type="bibr">13</xref>, 
 <xref rid="bib17" ref-type="bibr">17</xref>, 
 <xref rid="bib19" ref-type="bibr">19</xref>, 
 <xref rid="bib20" ref-type="bibr">20</xref>, 
 <xref rid="bib21" ref-type="bibr">21</xref>, 
 <xref rid="bib22" ref-type="bibr">22</xref>, 
 <xref rid="bib23" ref-type="bibr">23</xref> Further studies are required to define the immune response to SARS-CoV-2 in critically ill patients and in those with comorbidities and those who are immunocompromised, and to establish the viral burden that various aerosol-generating procedures generate in these patients.
</p>
